All Posts Tagged With: "EXEL"
(AKRX) Company News for June 07, 2011 – Corporate Summary
• Share prices of home nursing provider Amedisys, Inc.(NASDAQ:AMED) fell 7.41% after CRT Capital reduced its earnings estimates for fiscal 2011
• According to Canaccord Genuity, data from a trial of...
(SNY) Sanofi-Aventis Announces Agreement to Acquire TargaGen
Sanofi-Aventis (SNY) continues to work on expanding its oncology portfolio with the company recently entering into an agreement to acquire TargaGen Inc. TargaGen, a privately-held US biopharmaceutical company,...
(EXEL) Exelixis Presents Positive Drug Trial Data
Recently, Exelixis Pharma (EXEL) presented positive data from a mid-stage trial of its lead candidate, XL184. The drug, which is being co-developed with Bristol-Myers Squibb (
23May2010 | vitalstocks | 0 comments | Continued(EXEL) Exelixis Pharma First Quarter Report Narrows Loss
Exelixis Pharma (EXEL) reported a first quarter loss per share of 25 cents, better than a loss of 34 cents in the year-ago period. However Incorporatedluding restructuring expenses of $16.1 million, loss...